Trends in Drug Delivery Review Article
Morphine: A Pharmacological Perspective on Its Cancer Pain Management
Abstract
Morphine continues to be a key treatment in managing cancer pain because of its strong pain-relieving effects and established clinical history. Despite the emergence of alternative opioids and pain management therapies, morphine continues to be widely prescribed, particularly in palliative care settings. However, its use has been accompanied by concerns regarding tolerance, dependence, and adverse effects, which complicate long-term administration. This review explores the pharmacological aspects of morphine in cancer pain management, including its pharmacokinetics, mechanism of action, and the challenges it poses for patients. Special attention is given to pediatrics, geriatrics, and patients with renal or liver impairment. The article also discusses emerging therapeutic strategies, such as transdermal delivery systems, multimodal analgesia, and personalized medicine approaches, to improve pain control while minimizing side effects. Future research avenues and potential innovations in opioid therapies, including kappa and delta receptor agonists, provide promising directions to address the global challenge of cancer pain relief.
Keywords
References (13)
- Sheldon TA. Making evidence synthesis more useful for management and policy-making. Journal of Health Services Research & Policy. 2005;10(1_suppl):1-5. doi:10.1258/1355819054308521
- Colldén G, Tschöp MH, Müller TD. Therapeutic Potential of Targeting the Ghrelin Pathway. Int J Mole Sci. 2017;18(4):798. https://doi.org/10.3390/ ijms 18040798.
- Schug SA, Chandrasena C. Pain management of the cancer patient. Expert Opinion on Pharmacotherapy. 2014;16(1):5-15. doi:10.1517/14656566.2015.980723
- TAN T, KURAMOTO M, TAKAHASHI T, NAKAMURA H, NAKANISHI Y, IMASATO Y, et al. Characteristics of the gastrointestinal absorption of morphine in rats. Chemical and Pharmaceutical Bulletin. 1989;37(1):168-173. doi:10.1248/cpb.37.168
- Säwe J, Dahlström B, Paalzow L, Rane A. Morphine kinetics in cancer patients. Clinical Pharmacology and Therapeutics. 1981;30(5):629-635. doi:10.1038/clpt.1981.214
- Haileselassie W, Mulugeta T, Tigeneh W, Kaba M, Labisso WL. The Situation of Cancer Treatment in Ethiopia: Challenges and Opportunities. Journal of Cancer Prevention. 2019;24(1):33-42. doi:10.15430/jcp.2019.24.1.33
- Satija A, Ahmed SM, Gupta R, Ahmed A, Rana SP, Singh SP, et al. Breast cancer pain management-A review of current & novel therapies. Indian J Med Res. 2014 Feb 1;139(2):216–25.
- Schuster M, Bayer O, Heid F, Laufenberg-Feldmann R. Opioid Rotation in Cancer Pain Treatment. Deutsches Ärzteblatt international. 2018. doi:10.3238/arztebl.2018.0135
- Ballantyne JC. Chronic Pain Following Treatment for Cancer: The Role of Opioids. The Oncologist. 2003;8(6):567-575. doi:10.1634/theoncologist.8-6-567
- WHO Expert Committee on Cancer Pain Relief and Active Supportive Care & World Health Organization. (1990) Cancer pain relief and palliative care: Report of a WHO expert committee [meeting held in Geneva from 3 to 10 July 1989]. World Health Organization. https://iris.who.int/handle/10665/39524.
- Rosenblum A, Marsch LA, Joseph H, Portenoy RK. Opioids and the treatment of chronic pain: Controversies, current status, and future directions. Experimental and Clinical Psychopharmacology. 2008;16(5):405-416. doi:10.1037/a0013628
- Bhattarai P, Phillips JL. The role of digital health technologies in management of pain in older people: An integrative review. Archives of Gerontology and Geriatrics. 2017;68:14-24. doi:10.1016/j.archger.2016.08.008
- Leppert W, Krajnik M, Wordliczek J. Delivery systems of opioid analgesics for pain relief: A review. Current pharmaceutical design. 2013 Dec 1;19(41):7271–93.